Patents by Inventor Kay Faaberg

Kay Faaberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230117744
    Abstract: The present disclosure provides compositions, for example vaccine compositions comprising live, attenuated coronavirus. The disclosure also provides methods of using coronavirus vaccines, including methods of treating and/or preventing coronavirus infections, and provides methods of preparing coronavirus vaccines.
    Type: Application
    Filed: March 23, 2021
    Publication date: April 20, 2023
    Inventors: Susan Baker, Xufang Deng, Kelly Milton Lager, Kay Faaberg, Alexandra DeVries
  • Patent number: 10294459
    Abstract: This disclosure provides isolated infectious polynucleotides, such as infectious clones, having a nucleotide sequence with identity to PRRS viruses such as VR-2332, Lelystad, or others, and optionally further including a deletion in a region of ORF1 that encodes the nsp2 polypeptide.
    Type: Grant
    Filed: July 8, 2015
    Date of Patent: May 21, 2019
    Assignee: Regents of the University of Minnesota
    Inventors: Kay Faaberg, Jun Han, Gongping Liu, Yue Wang
  • Publication number: 20180333482
    Abstract: Coronaviruses, vaccines comprising the same, and methods for preventing disease. One embodiment of such includes a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a non-structural protein (nsp)-15, the replicase gene encoding the nsp15 and causes any change, including mutations and/or deletions, that affects the stability or activity of the nsp15.
    Type: Application
    Filed: March 2, 2018
    Publication date: November 22, 2018
    Inventors: Susan Baker, Xufang Deng, Matthew Hackbart, Robert Mettelman, Anna Mielech, Amornrat O'Brien, Kay Faaberg, Kelly Milton Lager
  • Publication number: 20170130207
    Abstract: This disclosure provides isolated infectious polynucleotides, such as infectious clones, having a nucleotide sequence with identity to PRRS viruses such as VR-2332, Lelystad, or others, and optionally further including a deletion in a region of ORF1 that encodes the nsp2 polypeptide.
    Type: Application
    Filed: July 8, 2015
    Publication date: May 11, 2017
    Inventors: Kay Faaberg, Jun Han, Gongping Liu, Yue Wang